BMJ5h
Overview: brain tumour diagnosis and management/Royal College of Physicians guidelines
Correspondence to: Dr Robert Grant Department of Clinical Neurosciences, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK; rgrantskull.dcn.ed.ac.uk This article is intended to reflect the ...
BMJ23h
Pathogenic role of anti-cN1A autoantibodies in sporadic inclusion body myositis
Background Sporadic inclusion body myositis (sIBM) is an intractable muscle disease that frequently affects elderly people. Autoantibodies recognising cytosolic 5’-nucleotidase 1A (cN1A) were found in ...
BMJ1d
Sex differences for phenotype in pathologically defined dementia with Lewy bodies
Introduction Sex differences in dementia with Lewy bodies (DLB) have been reported in clinically defined cohorts; however, clinical diagnostic accuracy in DLB is suboptimal and phenotypic differences ...
BMJ1d
Sentinel lesions of primary CNS lymphoma.
Some patients ultimately diagnosed with primary CNS lymphoma (PCNSL) have transient symptomatic contrast enhancing lesions. These "sentinel lesions" of PCNSL recede spontaneously or with ...
BMJ2d
Nerve conduction studies: essentials and pitfalls in practice
Department of Clinical Neurophysiology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK Correspondence to: Dr Arup Mallik Department of Clinical Neurophysiology, Institute ...
BMJ3d
Bladder dysfunction in hereditary spastic paraplegia: what to expect?
Correspondence to Dr M Braschinsky, Department of Neurology, University of Tartu, Puusepa 2, Tartu 51014, Estonia; mark.braschinsky{at}kliinikum.ee Background Hereditary spastic paraplegia (HSP) ...
BMJ1d
Location of intracranial aneurysms is the main factor associated with rupture in the ICAN population
Correspondence to Dr Romain Bourcier, Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nantes, L’institut du thorax, Inserm 1087, CNRS, UNIV Nantes, University Hospital ...
BMJ1d
The role of the axolemma in the initiation of traumatically induced axonal injury
Mr MO Fitzpatrick, Department of Neurosurgery, Institute of Neurological Sciences, Southern General Hospital NHS Trust, Glasgow, UK. If you wish to reuse any or all ...
BMJ1d
I02 Systemic injection of exosomal sirna significantly reduced huntingtin expression in transgenic mice of huntington’s disease
Background Cell-derived exosomes have been demonstrated to be efficient carriers of small RNAs into brain tissue. However, the therapeutic effect of exosome-mediated siRNA has not been tested in ...
BMJ1d
Brief cognitive assessment for patients with cerebral small vessel disease
Background: Cerebral small vessel disease is a common cause of cognitive impairment and vascular dementia. The cognitive deficit differs from that in Alzheimer’s disease, with greater ...
BMJ4d
NICE guideline on ME/CFS: robust advice based on a thorough review of the evidence
In 2021, the National Institute for Health and Care Excellence produced an evidence-based guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a ...
BMJ5d
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging
Dr R Barber, Institute for the Health of the Elderly, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne, NE4 6BE, U.K. Tel +(0)191 256 3274 ext. 22986; fax +(0)191 219 5048; email ...